Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H26O5 |
| Molecular Weight | 322.396 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C2C(=O)O1
InChI
InChIKey=DWTTZBARDOXEAM-GXTWGEPZSA-N
InChI=1S/C18H26O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h10-12,14,19-21H,2-9H2,1H3/t12-,14+/m0/s1
| Molecular Formula | C18H26O5 |
| Molecular Weight | 322.396 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/6351181 and http://www.ncbi.nlm.nih.gov/pubmed/20002219
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/6351181 and http://www.ncbi.nlm.nih.gov/pubmed/20002219
Zeranol is a non-steroidal anabolic growth promoter with potent estrogenic activity that is widely used as a growth promoter in the US beef industry. It is a mycotoxin, derived from fungi in the Fusarium family, it is an estrogen agonist. Zeranol is approved for use as a growth promoter in livestock, including beef cattle, in the United States. In Canada, it is approved for use in beef cattle only. Zeranol was officially banned in Europe due to safety concerns because of its potential carcinogenic and endocrine-disrupting biological activity. Merck Animal Health markets zeranol under the brand name Ralgro. It has being shown, that zeranol may increase cancer cell proliferation in already existing breast cancer.
Originator
Sources: http://www.google.ru/patents/US8674120
Curator's Comment: The first process for producing Zeranol described by Urry et al, Tetrahedron Letters, 1966, 27, 3109-3114
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3401 Sources: http://www.ncbi.nlm.nih.gov/pubmed/20966043 |
4.0 µM [EC50] | ||
Target ID: CHEMBL242 Sources: http://www.ncbi.nlm.nih.gov/pubmed/12828470 |
24.0 nM [EC50] | ||
Target ID: GO:0006939 Sources: http://www.ncbi.nlm.nih.gov/pubmed/9147025 |
15.62 µM [IC50] | ||
Target ID: CHEMBL2093866 Sources: http://www.ncbi.nlm.nih.gov/pubmed/9867255 |
1.8 nM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | RALGRO Approved UseFor increased weight gain and for improved feed conversion of weaned beef calves, growing beef cattle, feedlot steers and feedlot heifers. For increased rate of weight gain of suckling beef calves. Launch Date1968 |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
0.32 μg × eq/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6624136/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
ZERANOL blood | Homo sapiens population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
22 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6624136/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
ZERANOL blood | Homo sapiens population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. | 2015-02 |
|
| Selectivity of natural, synthetic and environmental estrogens for zebrafish estrogen receptors. | 2014-10-01 |
|
| Effect of zeranol on expression of apoptotic and cell cycle proteins in murine placentae. | 2013-12-06 |
|
| Zeranol upregulates corticotropin releasing hormone expression in the placental cell line JEG-3. | 2013-06-07 |
|
| Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line. | 2012-02 |
|
| miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. | 2011 |
|
| Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications. | 2010-02-15 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Phytoestrogen alpha-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells. | 2006 |
|
| Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types. | 2004-07 |
|
| The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma. | 2003-12-15 |
|
| Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters. | 2001-05 |
|
| Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. | 2001-05 |
|
| Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. | 2000-05 |
|
| Inhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture. | 1999-12 |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Subcutaneous implantation on the posterior aspect of the middle one-third of the ear by means of an implant gun.
RALGRO (Zeranol):
Beef cattle: One implant containing 36 mg zeranol.
Feedlot lambs: One implant containing 12 mg. zeranol
Route of Administration:
Transdermal
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/27220457
Zeranol (2‑50 nM) was able to significantly promote cell proliferation, aromatase mRNA expression, aromatase activity and estrogen production in primary cultured human breast preadipocytes
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:45:24 GMT 2025
by
admin
on
Wed Apr 02 08:45:24 GMT 2025
|
| Record UNII |
76LO2L2V39
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 556.760
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
||
|
NCI_THESAURUS |
C2182
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
||
|
CFR |
21 CFR 522.2680
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB11478
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
D015029
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
247-769-0
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
1368476
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB00148MIG
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
m11589
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000079414
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL450613
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
2844
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
2999413
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
2860
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
DTXSID4022315
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
26538-44-3
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
ZERANOL
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
C76826
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
76LO2L2V39
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY | |||
|
76LO2L2V39
Created by
admin on Wed Apr 02 08:45:24 GMT 2025 , Edited by admin on Wed Apr 02 08:45:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |